Upon exposure to gemcitabine, HuR translocates from the nucleus to a cytoplasmic localization in pancreatic cancer cells and, through its dCK regulating activity, sensitizes the cells to gemcitabine [90,91]. This evidence concerns the gene ELAVL1 and pancreatic neoplasm.